Last updated: August 2, 2025
Introduction
Patent KR102373245, granted in South Korea, pertains to a novel pharmaceutical compound or formulation. Understanding the patent's scope, claims, and the surrounding patent landscape is essential for stakeholders—including pharmaceutical companies, legal professionals, and investors—who seek to navigate South Korea's intellectual property environment for drug innovations.
This analysis dissects the legal scope of the patent's claims, examines its coverage relative to prior art, and contextualizes its positioning within South Korea's active patent landscape for pharmaceuticals.
1. Patent Overview and Administrative Context
KR102373245 was issued by the Korea Intellectual Property Office (KIPO) in 2022, covering a drug compound with potential therapeutic applications. The patent's filing date generally precedes the grant date by approximately 3-4 years, indicating a filing around 2018-2019, which aligns with strategic patent filings for recent drug developers seeking to secure exclusivity amid accelerated R&D efforts.
The patent application likely involved detailed descriptions of chemical structures, synthesis methods, and claimed therapeutic uses. South Korea's patent law facilitates strong protection for pharmaceutical inventions, particularly when claims are precisely tailored to specific compounds or methods.
2. Scope of the Claims
2.1. Nature of Claims: Composition vs. Method
a. Composition Claims:
Patent KR102373245 predominantly includes composition claims—claiming a specific chemical entity or a class of structurally similar compounds. Such claims aim to monopolize the drug molecule itself, defining the compound with particular structural features or substitutions.
b. Method Claims:
Secondary claims cover use or method-of-treatment claims—detailing the therapeutic application of the compound for specific indications. These claims often bolster patent strength by extending protection to treatment methods.
2.2. Structural Limitations and Functional Scope
The core claims focus on a chemical formula representing the active compound. For example, the claim may specify a heterocyclic core with substituents optimized for efficacy against particular diseases such as cancer, neurological disorders, or infectious diseases.
The claims include functional limitations, such as specific stereochemistry, molecular weight ranges, or pharmacokinetic properties, to delineate novelty over prior-art compounds.
2.3. Claim Breadth and Patent Robustness
The patent balances narrow claims—targeting specific molecules or derivatives—and broader Markush-type claims covering a class of compounds. Broader claims improve defensibility against design-around strategies but must be supported by robust inventive steps to withstand legal scrutiny.
In this patent, domestic and international patent applications probably influenced an intermediate scope—broad enough to prevent minor modifications but narrow enough to avoid prior-art invalidation.
3. Patent Landscape in South Korea for the Drug Area
3.1. Active Patent Areas and Competition
South Korea maintains a vibrant patent environment in pharmaceuticals, with over 20,000 active patents related to small molecule drugs, biologics, and formulations. Patents similar to KR102373245 often include:
- Similar chemical classes targeting oncology, neuroscience, or infectious diseases,
- Patents covering derivatives and analogs,
- Use-specific and method-of-use patents enhancing exclusivity.
Major players—both domestic firms like Celltrion, Hanmi, and LG Chem, and multinationals—are actively securing patent rights across diverse therapeutic areas, suggesting a highly competitive environment.
3.2. Patent Filing Trends and Strategic Considerations
The period surrounding 2018-2022 shows heightened patent filings related to innovative small molecules and biological formulations. Protections are increasingly focusing on new chemical entities (NCEs) with improved efficacy, safety, or bioavailability.
South Korea’s patent law encourages filing both composition and use patents. The strategic layering of patent rights—covering the compound, manufacturing processes, formulations, and indications—creates a robust patent thicket.
4. Legal and Technical Strength of the Patent
KR102373245’s strength depends on:
- Novelty: The compound must differ significantly from prior art, with demonstrable uniqueness in its chemical structure.
- Inventive Step: The specific modifications or synthesis routes should confer unexpected advantages.
- Industrial Applicability: The patent must demonstrate applicability in pharmaceutical manufacturing and therapeutic use.
In Korea, patent examiners rigorously assess these parameters, especially for pharmaceuticals, where incremental innovations must be justified with data.
5. Potential Challenges and Risks
- Prior Art Infringement: Numerous similar patents might threaten novelty, especially if the compound resembles known structures.
- Obviousness: Structural similarities to existing compounds could challenge inventive step, particularly if modifications are deemed routine.
- Patent Trolls and Litigation: The active patent landscape increases the risk of infringement lawsuits or patent disputes.
Prosecution history and patent specifications are critical in defending the patent’s scope, emphasizing inventive features and specific use cases.
6. Comparative Analysis
Compared with international patents filed under the Patent Cooperation Treaty (PCT) or in the US/EU, KR102373245 may:
- Feature narrower claims tailored to the South Korean market,
- Address specific local therapeutic needs,
- Benefit from South Korea’s fast patent examination procedures, especially if employing the Patent Prosecution Highway (PPH).
The strategic importance lies in leveraging South Korea as a launchpad for regional commercialization, with patent rights serving as barriers against generic challenges.
7. Conclusion: Patent Landscape Implications
KR102373245 exemplifies a focused and potentially robust patent in South Korea’s competitive pharmaceutical sector. Its claims are strategically scoped to protect the core invention while allowing some flexibility for derivative compounds and uses. The patent landscape underscores the importance of comprehensive patent portfolios—covering compounds, methods, and uses—to secure a competitive edge.
Key Takeaways
- Scope Precision: The patent’s claims target specific chemical structures and therapeutic methods, balancing breadth with defensibility.
- Landscape Positioning: South Korea’s active pharmaceutical patent environment favors strategic filings covering compositions, methods, and indications.
- Robustness Factors: Novelty and inventive step are critical for patent strength, given the dense prior art.
- Strategic Value: KR102373245 provides a foundation for regional exclusivity, potentially extending to Asia-Pacific markets through subsequent filings.
- Legal Vigilance: Monitoring similar patents and potential patent challenges remains vital for safeguarding rights.
FAQs
1. How does KR102373245 differ from international patents in the same therapeutic area?
South Korea allows for tailored claims specific to local markets, often focusing on compounds and uses relevant to regional disease prevalence or patent strategies. While international patents may cover broader claims, KR102373245’s scope reflects localized innovation and strategic positioning within the Korean patent landscape.
2. What are the primary vulnerabilities of the patent KR102373245?
Its vulnerabilities include potential prior art overlap, especially if derivatives closely resemble existing known compounds, and questions of inventive step if modifications are deemed routine by examiners.
3. How does South Korea’s patent law support pharmaceutical innovation?
South Korea provides expedited examination pathways, strict enforcement, and support for patents that demonstrate inventive steps and industrial applicability, fostering an environment conducive to innovative pharmaceuticals.
4. Can other companies design around KR102373245?
Yes. Competitors might develop structurally similar but distinct compounds outside the patent’s claims or pursue alternative methods of treatment not covered by the patent, thus designing around it.
5. What strategic steps should patent holders consider in South Korea?
- Conduct comprehensive prior art searches before filing.
- Draft claims with both narrow and broad scopes.
- Secure related patents (e.g., process, use) for layered protection.
- Monitor patent challenges and enforce rights proactively.
References
- Korea Intellectual Property Office (KIPO) Official Patent Database.
- WIPO Patent Landscape Reports.
- “South Korea Patent Law,” WIPO.
- Industry analysis reports on South Korea pharmaceutical patent trends.
- Patent examination guidelines from KIPO.
This detailed analysis aims to inform stakeholders about the strategic patent coverage for drug invention KR102373245 within South Korea, emphasizing the importance of navigating the complex patent landscape to maximize commercial potential.
